tiprankstipranks
Board Reshuffle at Petros Pharmaceuticals Following Resignations
Company Announcements

Board Reshuffle at Petros Pharmaceuticals Following Resignations

Don't Miss Our Christmas Offers:

The latest update is out from Petros Pharmaceuticals ( (PTPI) ).

John Shulman and Greg Bradley, both members of the board of directors at Petros Pharmaceuticals, Inc., have recently stepped down from their positions. Their resignations, effective October 1 and 2, 2024, respectively, were not due to any disputes or disagreements with the company’s management or business protocols. This change in the company’s leadership could be of interest to stakeholders and market watchers tracking corporate governance and stability.

See more insights into PTPI stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyPetros to shift focus to development of tech as Rx-to-OTC switch solution
TipRanks Auto-Generated NewsdeskPetros Pharmaceuticals Amends President’s Employment Terms
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App